FDA.reportPublic FDA data

Application 201445

Type
ANDA
Sponsor
CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ACYCLOVIRACYCLOVIRCAPSULE;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-5739AcyclovirAcyclovirA-S Medication SolutionsANDACurrent
67296-1723AcyclovirAcyclovirRedPharm Drug, Inc.ANDACurrent
67296-1723AcyclovirAcyclovirRedPharm Drug, Inc.ANDACurrent
68071-2235AcyclovirAcyclovirNuCare Pharmaceuticals,Inc.ANDACurrent
68071-2235AcyclovirAcyclovirNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4528AcyclovirAcyclovirNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4528AcyclovirAcyclovirNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4528AcyclovirAcyclovirNuCare Pharmaceuticals,Inc.ANDACurrent
70518-0806AcyclovirAcyclovirREMEDYREPACK INC.ANDACurrent
70518-0806AcyclovirAcyclovirREMEDYREPACK INC.ANDACurrent
71209-004AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-004AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-004AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-004AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71335-1013AcyclovirAcyclovirBryant Ranch PrepackANDACurrent
71335-1013AcyclovirAcyclovirBryant Ranch PrepackANDACurrent
71335-1013AcyclovirAcyclovirBryant Ranch PrepackANDACurrent
72241-028AcyclovirAcyclovirModavar Pharmaceuticals LLCANDACurrent
72241-028AcyclovirAcyclovirModavar Pharmaceuticals LLCANDACurrent
75834-124AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent
75834-124AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent
75834-124AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent